Insomnia
📧 Sign up to get email alerts when something new happens for Insomnia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-08-11Clinical Trial Update: Effect of Guanfacine Extended-Release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia [Phase 4]
Phase 4 trial evaluating guanfacine extended-release for ADHD-associated insomnia was terminated; results were posted in 2014.
-
FDA approval · 2014-08-08FDA Approved: SILENOR — Supplemental Application (Currax Pharmaceuticals LLC)
FDA approves a supplemental application for Silenor (doxepin hydrochloride) from Currax Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2014-08-06Clinical Trial Update: A Six Week, Double-Blind Randomized, Efficacy and Safety, Sleep Lab Trial With Esmirtazapine (Org 50081) (P05707) [Phase 3]
Phase 3 double-blind trial evaluating esmirtazapine (Org 50081) for efficacy and safety in insomnia; results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-08-06Clinical Trial Update: Blood Pressure, Heart Rate Variability & Sleep in Veterans With PTSD [NA]
A clinical trial evaluating blood pressure, heart rate variability, and sleep in veterans with PTSD and related conditions has been terminat…
-
CLINICAL_TRIALS trial_result · 2014-08-05Clinical Trial Update: Efficacy and Safety Study of Org 50081 (Esmirtazapine) in Elderly Participants (P05709) [Phase 3]
Phase 3 trial updating efficacy and safety of Org 50081 (Esmirtazapine) in elderly with insomnia-related disorders; results posted after com…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-08-04Clinical Trial Update: Evaluation of Yoga for Sleep Disturbances in Post Traumatic Stress Disorder (PTSD) [NA]
A Brigham and Women's Hospital-sponsored trial evaluating yoga for sleep disturbances in PTSD has completed.
-
CLINICAL_TRIALS trial_result · 2014-08-01Clinical Trial Update: A 6-Month Efficacy and Safety Study of Org 50081 in Adult Patients With Chronic Primary Insomnia (21106/P05701/MK-8265-002) [Phase 3]
A Phase 3 clinical trial update reports on the 6-month efficacy and safety of Org 50081 in adults with chronic primary insomnia; results hav…
-
CLINICAL_TRIALS trial_result · 2014-07-30Clinical Trial Update: Fifty Two Week Extension Trial of Org 50081 (Esmirtazapine) in the Treatment of Insomnia (P05708) [Phase 3]
Phase 3 52-week extension trial of esmirtazapine (Org 50081) for insomnia completed; results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-07-21Clinical Trial Update: Behavioral Insomnia Therapy for Fibromyalgia [NA]
This document reports that a clinical trial evaluating Behavioral Insomnia Therapy for fibromyalgia has completed. The study addressed insom…
-
CLINICAL_TRIALS trial_result · 2014-07-15Clinical Trial Update: Efficacy & Safety of Eszopiclone (Lunesta) in Nursing Home Patients [Phase 4]
Phase 4 trial evaluating the efficacy and safety of eszopiclone (Lunesta) in nursing home patients with insomnia, with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2014-07-10Clinical Trial Update: Study of the Safety and Effectiveness of Esmirtazapine in Participants With Chronic Primary Insomnia (P05706) [Phase 3]
A Phase 3 clinical trial assessing the safety and effectiveness of esmirtazapine for chronic primary insomnia has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: The Ability of Songha Night ® to Improve Sleep in Patients With Mild to Moderate Sleep Disturbances [Phase 3]
This entry reports the completion of Boehringer Ingelheim's Phase 3 trial evaluating Songha Night for sleep initiation and maintenance disor…
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Efficacy and Safety of Eschscholtzia Californica in Treating Primary Insomnia [Phase 3]
Phase 3 trial evaluating Eschscholzia californica for primary insomnia has been terminated, with efficacy and safety data reported.
-
CLINICAL_TRIALS trial_result · 2014-07-07Clinical Trial Update: A Long-Term Safety Study of Org 50081 (Esmirtazapine) in Elderly Outpatients With Chronic Primary Insomnia (176005/P05697/MK-8265-001) [Phase 3]
Phase 3 long-term safety study of Org 50081 (Esmirtazapine) in elderly outpatients with chronic primary insomnia completed; results posted i…
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Twenty-six Week Extension Trial of Org 50081 (Esmirtazapine) in Outpatients With Chronic Primary Insomnia (176003/P05721/MK-8265-007) [Phase 3]
Phase 3 extension trial of esmirtazapine (ORG 50081) in outpatients with chronic primary insomnia; trial terminated with posted results in 2…
-
CLINICAL_TRIALS withdrawal · 2014-06-17Clinical Trial Update: Insomnia in Patients Undergoing Chemotherapy and Radiation Therapy for Head and Neck Cancer
A Vanderbilt University-led clinical trial investigating insomnia in patients with head and neck cancer undergoing chemotherapy and radiatio…
-
FDA approval · 2014-06-10FDA Approved: ESZOPICLONE — Original Application (Bionpharma Inc.)
FDA approved Bionpharma Inc.'s Original Application for eszopiclone, granting generic approval for eszopiclone tablets used to treat insomni…
-
FDA approval · 2014-06-05FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Hydroxyzine Hydrochloride from Teva Pharmaceuticals USA, Inc., granting regulatory clearance…
-
FDA approval · 2014-06-04FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (KVK-Tech, Inc.)
FDA approved a supplemental application for hydroxyzine hydrochloride from KVK-Tech, Inc., indicating updated regulatory authorization for t…
-
FDA approval · 2014-06-04FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's supplemental application for hydroxyzine hydrochloride, authorizing changes to the approved produc…
-
FDA approval · 2014-06-03FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for hydroxyzine hydrochloride (HYDROXYZINE HYDROCHLORIDE) from Chartwell RX, LLC.
-
CLINICAL_TRIALS research · 2014-06-03Clinical Trial Update: Cognitive Behavioral Therapy for Insomnia in People With Chronic Obstructive Pulmonary Disease(COPD) [NA]
This entry reports the completion of a clinical trial evaluating cognitive behavioral therapy for insomnia in people with chronic obstructiv…
-
FDA approval · 2014-05-29FDA Approved: LUNESTA — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for LUNESTA (eszopiclone) submitted by Waylis Therapeutics LLC. This action grants an additional…
-
CLINICAL_TRIALS trial_result · 2014-05-26Clinical Trial Update: Estrogen for Treating Depression in Menopausal Women With Hot Flashes and Insomnia [Phase 4]
Phase 4 clinical trial update on using estrogen to treat depression in menopausal women with hot flashes and insomnia.
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia [Phase 4]
Phase 4 trial evaluating functional melatonin replacement to treat sleep disruptions in individuals with tetraplegia due to spinal cord inju…